Bookmark and Share

Last Minute:          For more news, click here.

Authentication
       
       
Remember me? 

Rise of
+0.21 (+1.52%) Teva Pharmaceutic - [Ticker: TEVA]Chart Teva Pharmaceutic  News Teva Pharmaceutic  Download Historical Prices for Metastock Teva Pharmaceutic and Others  Technical Analysis Teva Pharmaceutic  
Last Trade14.01Last Trade Time2017-11-01 - 19:35:00
Variation+0.21 (+1.52%)Open13.55
High14.08Low13.38
Volume21,287,058Average Volume (3m)0
YieldBid / Ask14.01 x 8,100 - 14.02 x 6,000
Former Close13.8052 Week Range[0.00 - 0.00]
PER0.00%EPS0.00
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
Teva Pharmaceutic -  [Ticker: TEVA] chart
Change to Teva Pharmaceutic Interactive Technical Analysis Chart

Last 10 Forum Topics about Teva Pharmaceutic:
No topics about Teva Pharmaceutic [TEVA] have been found, but a search on the Forum for more topics related to Teva Pharmaceutic is advised.

 News about Teva Pharmaceutic [TEVA]:   (ordered by relevance)
  1. Investors question green tint of Teva's $5bn sustainability bond  Financial Times
  2. CSRWire - Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets  CSRwire.com
  3. Teva Announces Successful Upsize of Sustainability-Linked Senior Notes Offering and Pricing of $5000000000 of Sustainability-Linked Senior Notes  Business Wire
  4. Teva to Sell Record $5 Billion of Sustainability-Linked Bonds  Bloomberg
  5. Teva Pharmaceuticals plans $5 billion sustainability-linked bond tied to climate and access to medicine targets  MarketWatch
Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement  Business Wire J&J, Teva Beat $50 Billion Opioid Case in First Industry Win  Bloomberg Amgen, Biohaven, Lilly and Teva plowed plenty into marketing migraine meds. Is it working?  FiercePharma Should You Be Concerned About Teva Pharmaceutical Industries Limited's (NYSE:TEVA) ROE?  Nasdaq Worldwide Digital Dose Inhaler Industry to 2026 - Featuring Lupin, Novartis and Teva Pharmaceutical Industries Among Others  PRNewswire By selling bonds tied to drug access and climate goals, Teva takes pharma in a new direction - STAT  STAT GlaxoSmithKline LLC v. Teva Pharms. USA, Inc. | Robins Kaplan LLP - JDSupra  JD Supra From Cuyana to Teva  Fast Company 3 Undervalued Warren Buffett Stocks  Morningstar Sun: TASE falls on Omicron variant concerns  Globes The Best Cyber Monday Shoe Deals (2021): Allbirds, Nike, Ugg, Tevas, and More  Condé Nast Traveler Global Autoinjectors Markets Report 2021-2026: Growing Prevalence of Targeted Therapies, Rising Incidence of Anaphylaxis, and Increasing Number of Regulatory Approvals - ResearchAndMarkets.com  Business Wire Teva halts output at U.S. drug plant after FDA flags concerns  Reuters Glaxo's Win in Case Against Teva Lifts Other Drugmakers  Bloomberg Teva Pharmaceuticals' Motion to Dismiss Denied  Policy & Medicine 9 @ 9: Teva Slippers, Avoiding A 'swamp Butt' And Live Action 'Simpsons' Open | Chicago News  Oakland News Now Is A Fall Imminent For Teva Stock After Its Recent Rally?  Forbes Contraceptives Market revenue to cross USD 39 Bn by 2027: Global Market Insights Inc.  GlobeNewswire Teva must face government's kickback claims over Copaxone - judge  Reuters Why Teva Pharmaceutical Industries Shot Higher Today  Motley Fool Teva's pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug  FiercePharma Fitch Affirms Teva at 'BB-'; Outlook Remains Negative  Fitch Ratings Two pharma giants claim Irish-based Teva breached its patents  The Irish Times Teva and Bioeq Announce Commercial Partnership for Biosimilar  Business Wire Brussels' Teva probe reveals dark side of patent protections  Financial Times Antitrust: Commission opens formal investigation: Teva  EU News Mylan sues generic rival Teva over 'sophisticated scheme' to block Copaxone copycats  FiercePharma EXCLUSIVE Teva Pharm unlikely to reach deals to co-produce vaccines -CEO  Reuters NRx Pharmaceuticals Identifies Significantly Higher Likelihood of Surviving and Recovering from Critical COVID-19 in ZYESAMI® (aviptadil) Treated Patients Previously Administered Remdesivir  GlobeNewswire UK and Israel join forces to stop Iran gaining nuclear weapons  Telegraph.co.uk Teva taps new North American commercial chief as key meds Ajovy, Austedo lag their rivals  FiercePharma Teva reaches $925,000 settlement to resolve drug price-fixing claims  PMLiVE Why Teva Pharmaceuticals Has Two A-Products In The Bag  Seeking Alpha AstraZeneca, Merck KGaA, Pfizer, and Teva Team up with Tech and Investment Leaders to Launch New Biotech Innovation Lab  Pharmaceutical Technology Magazine Teva to Host Conference Call to Discuss Third Quarter 2021 Financial Results at 8 a.m. ET on October 27, 2021  Business Wire After cost-cutting spree, Teva chief Schultz nabs big pay bump to nearly $16M  FiercePharma EPR Podcast Episode 1 - Richard Daniell, Teva Pharmaceuticals  European Pharmaceutical Review AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals  Business Wire Class 2 Medicines Recall: Bristol Laboratories Limited, Brown & Burk UK Ltd, Teva UK Ltd, Irbesartan-containing and Losartan-containing products, EL (21)A/14  GOV.UK Teva, Glenmark accuse U.S. government of improperly expanding price-fixing case  FiercePharma Former Moderna CMO Zaks goes back to his Israeli roots, reemerging as Teva board director  FiercePharma Is Teva Pharmaceutical a Safe Stock to Buy Now?  Motley Fool Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 2021  Business Wire Teva to Present New Data from Growing Mental Health Portfolio at Psych Congress 2021  Yahoo Finance Antitrust: Commission fines Teva and Cephalon ?60.5 million  EU News Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate  Yahoo Finance Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to Treat Chronic Obstructive Pulmonary Disease (COPD), in the United States  Business Wire Is Teva Pharmaceutical Industries (NYSE:TEVA) Using Too Much Debt?  Nasdaq Israel-based Teva to invest $42 mln in new drug plant in Bulgaria  SeeNews Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report  Business Wire No joy for Ajovy: Teva's migraine drug can't find a convincing win in meta-analysis versus Biohaven, AbbVie meds  FiercePharma What To Do After Teva Stock Falls Below $10 Again  Seeking Alpha Teva to close Sudocrem plant in Dublin, 110 jobs to go  RTE.ie Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines  Fortune Teva Pharm sees growth in two main branded drugs in otherwise flat 2021  Reuters Generic-Drug Labeling Strategy Likely to Survive Teva Rehearing  Bloomberg J&J, Teva Opioid Trial May Signal Cost of Drug Maker Accords  Bloomberg Teva recalls single lot of cancer drug topotecan after complaint flags glass particulate in vial  FiercePharma Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO® (deutetrabenazine) Tablets in Adult Patients with Tardive Dyskinesia  Business Wire Teva Announces Launch of its Generic Erythromycin Tablets USP, Used to Treat or Prevent a Variety of Bacterial Infections, in the United States  Business Wire Teva Announces Launch of First Generic Version of AZOPT® (brinzolamide ophthalmic suspension) 1%, used to treat high pressure inside the eye, in the United States  Business Wire Teva Announces Ministry of Health, Labour and Welfare Approves AJOVY® (fremanezumab) Injection in Japan for the Preventive Treatment of Migraine in Adults  Business Wire Teva to Highlight Research in Respiratory Care at Upcoming 2021 American Thoracic Society International Conference  Business Wire Pinsent Masons advises Teva Pharmaceuticals on ?84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.  Out-Law.com Buffy the asthma inhaler? Teva taps 'Vampire Slayer' actress to raise inhaler misuse awareness  FiercePharma Teva Presents New Data at 7th European Academy of Neurology Congress Suggesting Socio-Economic Factors May Contribute to the Significant Under-Diagnosis of Migraine  Yahoo Finance Generic Makers to Challenge Ruling Upholding Teva Cancer Drug  Bloomberg Law On the trend trail with Teva ? sandal of the summer  Drapers Teva: Biosimilars In The US Will Become Like Complex Generics  Generics Bulletin English High Court finds Bayer patent obvious in win for Teva  Life Sciences Intellectual Property Review Teva Pharmaceutical's Ice-Cube Business Model  Seeking Alpha Teva sells its only manufacturing plant in Russia  The Pharma Letter Reflecting on Teva Pharmaceutical Industries' (NYSE:TEVA) Share Price Returns Over The Last Five Years  Simply Wall St Teva And TerraCycle Announce TevaForever Recycling Program For ?Well-Loved? Sandals  Forbes Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance at 8 a.m. ET on February 10, 2021  Business Wire Showcasing Teva's Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be presented, Including One Late-Breaker, on AJOVY® (fremanezumab-vfrm) Injection at the International Headache Society and European Headache  Business Wire AbbVie vs.Teva: Which Drug Manufacturing Stock is a Better Choice?  Yahoo Finance Teva Sets Ambitious Long-Term Environmental Goals As Part of  CSRwire.com LoA Update: Teva's extended-release risperidone for schizophrenia sees 5-point boost in regulatory potential following  Clinical Trials Arena Teva sees room for growth with FDA communications and complex generics, COO says  Endpoints News Teva receives EU Marketing Authorisation for Seffalair® Spiromax® and BroPair® Spiromax® (salmeterol xinafoate / fluticasone propionate)  Business Wire GSK, Teva on-again, off-again lawsuit is back on: Will 'skinny labeling' get a reprieve?  FiercePharma Teva Drug-Label Case Spurs Fresh Litigation as Judges Weigh Redo  Bloomberg Law Teva UK Enters Erectile Dysfunction Category With First Ever Rx-To-OTC Switch  HBW Insight Teva joins pharma's help-the-helpers trend with campaign for Canada's COVID caregivers  FiercePharma Teva Canada Provides New Patient Resource to Empower Those Living with Chronic Conditions  Business Wire Teva Wins New Hearing in Glaxo 'Skinny Label' Drug Patent Case  Bloomberg Law Teva Generic Price-Fixing Securities Suit Gets Class Status (1)  Bloomberg Law Teva Pharmaceutical Industries Enters Oversold Territory (TEVA)  Nasdaq Teva to Present 8 Abstracts on AJOVY® (fremanezumab-vfrm) Injection and Hold Symposium on Healthcare Disparities at WCN  Yahoo Finance Biogen sues Teva over MS generic  Life Sciences Intellectual Property Review Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable Risperidone for Patients with Schizophrenia  Business Wire Teva appeals to court to keep 'incredibly damaging' Hollywood parody videos under wraps in New York opioid case  Endpoints News Teva Canada Welcomes Efforts to Address Critical Drug Supply in the Federal Budget  Canada NewsWire US FDA nod to Teva for key specialty product to weigh on Sun Pharma  Business Standard 'Sole' Mates: Teva and Stance Unite, Release Faux Pas Collab  GearJunkie Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2021 American Headache Society (AHS) Annual Meeting, Showcasing Teva's Longstanding Heritage in the Management of Migraine  Business Wire Teva to lay off 200 in Israel - Globes  Globes Federal Circuit Decides Teva-Lilly Spat for Antibody Compositions and Methods  JD Supra
For more news about Teva Pharmaceutic click here:
Teva Pharmaceutic News
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2021 - TR4DER.com, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources